RUA Life Sciences Past Earnings Performance

Past criteria checks 0/6

RUA Life Sciences's earnings have been declining at an average annual rate of -29.2%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 33% per year.

Key information

-29.2%

Earnings growth rate

-18.5%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate33.0%
Return on equity-50.1%
Net Margin-100.1%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

Feb 15
The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

Revenue & Expenses Breakdown
Beta

How RUA Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:RUA Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 232-231
30 Jun 232-231
31 Mar 232-231
31 Dec 222-221
30 Sep 222-231
30 Jun 222-221
31 Mar 222-221
31 Dec 212-230
30 Sep 212-230
30 Jun 212-230
31 Mar 212-130
31 Dec 201-120
30 Sep 201-120
30 Jun 201-120
31 Mar 200-110
31 Dec 191-110
30 Sep 191-110
30 Jun 190-110
31 Mar 190-110
31 Dec 180010
30 Sep 180010
30 Jun 180010
31 Mar 180000
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 161010
30 Sep 161010
30 Jun 161010
31 Mar 161010
30 Sep 150-110
30 Jun 150010
31 Mar 151010
30 Sep 141010
30 Jun 140010
31 Mar 140010
30 Sep 130-100
30 Jun 130-200
31 Mar 130-210

Quality Earnings: RUA is currently unprofitable.

Growing Profit Margin: RUA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RUA is unprofitable, and losses have increased over the past 5 years at a rate of 29.2% per year.

Accelerating Growth: Unable to compare RUA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RUA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).


Return on Equity

High ROE: RUA has a negative Return on Equity (-50.08%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.